Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

GLP-1 diabetes drugs like Ozempic may modestly reduce cancer risks Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland ...

When the proposed three-way deal was first announced earlier this year, it prompted debate about the antitrust implications in part because Catalent is working with many of Novo Nordisk's ...

Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha. Skip to content Home page Seeking Alpha - Power to Investors About Premium Explore Alpha Picks Home ...